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Abstract Continuous processing in pharmaceutical
manufacturing is a relatively new approach that has generated
significant attention. While it has been used for decades in
other industries, showing significant advantages, the pharma-
ceutical industry has been slow in its adoption of continuous
processing, primarily due to regulatory uncertainty. This paper
aims to help address these concerns by introducing methods
for batch definition, raw material traceability, and sensor fre-
quency determination. All of the methods are based on
established engineering andmathematical principles, especial-
ly the residence time distribution (RTD). This paper intro-
duces a risk-based approach to address content uniformity
challenges of continuous manufacturing. All of the detailed
methods are discussed using a direct compaction manufactur-
ing line as the main example, but the techniques can easily be
applied to other continuous manufacturing methods such as
wet and dry granulation, hot melt extrusion, capsule filling,
etc.
Keywords Continuous Processing . Residence time
distribution . Traceability . Batch definition . Process
analytical technology (PAT)
Introduction
Pharmaceutical manufacturing has a long history of develop-
ing and manufacturing drug product in batches. This
production technique was used for industrial chemicals and
other consumer products long before the industrial revolution
(eighteenth century) when an initial shift from batch to con-
tinuous processing occurred. Due to continuous process ad-
vantages, today, the majority of commodity chemicals, petro-
chemicals, food, and consumer products are manufactured
continuously, leaving behind pharmaceuticals, which are still
made with traditional batch processes. Many sources have
suggested that pharmaceutical manufacturing has been frozen
in time due to regulatory requirements that generate large
amounts of paperwork, causing huge monetary cost in pro-
duction delays resulting from even minor manufacturing
changes (see, for example, aWall Street Journal article on this
topic [1]). This has lead to fearful, conservative cultures with-
in the industry, which would rather remain steadfast with old
and familiar technology rather than evolve with new technol-
ogies that improve the industry.
With the goal of modernizing and spurring technological
improvement in the regulation of pharmaceutical manufactur-
ing and product quality, in August 2002, the Food and Drug
Administration (FDA, http://www.fda.gov) launched a
regulatory modernization initiative, meant to encourage early
adoption of new technological advances, facilitate industry
application of modern quality management techniques,
encourage implementation of risk-based approaches, ensure
regulatory policies are based on state-of-the-art science, and
enhance the consistency and coordination of drug quality reg-
ulatory programs. [2] A series of guidances have since been
published, which further encourage significant changes to pro-
cesses used to manufacture pharmaceuticals. The FDA has
published the initial process analytical technology (PAT)
framework [3], which supports the move from static batch
processing to more dynamic approaches that mitigate the risk
of producing poor-quality product. The International Confer-
ence on Harmonization (ICH, http://www.ich.org)
* Fernando Muzzio
fjmuzzio@yahoo.com
1 Department of Chemical and Biochemical Engineering, Rutgers
University, 98 Brett Rd., Piscataway, NJ 08854, USA
J Pharm Innov (2016) 11:64–81
DOI 10.1007/s12247-015-9238-1
implemented a trio of quality guidances: Q8(R2), Q9, and
Q10 [4]–[5], which introduced valuable new concepts such
as quality by design (QbD).
Although the regulatory guidances describe in detail what
is necessary, they provide little explanation about how to ac-
complish it. To begin filling this gap, the International Society
for Pharmaceutical Engineering (ISPE, http://www.ispe.org)
launched the Product Quality Lifecycle Implementation
(PQLI) initiative in 2007. This initiative aims to provide prac-
tical solutions for implementation challenges of the ICH guid-
ances [6–8], while still recognizing that there are multiple
satisfactory ways to address the concepts described in the
guidelines [6]. However, there is little focus on providing
solutions that directly apply to continuous processing.
One of the main approaches to modernizing and improving
pharmaceutical manufacturing is continuous processing,
which in recent years has gained attention of both the industry
and regulatory authorities [9–17]. Continuous manufacturing
approaches have many advantages over traditional batch
methods, which have motivated many other industries to
adopt them [11, 18]. Continuous processing equipment has a
much smaller footprint leading to lower equipment costs. Be-
cause all the processing steps are interconnected, no interme-
diate storage is needed, lowering the necessary material inven-
tory. Unlike batch processing, the smaller scale and ability to
process different amounts of material simply by changing the
production timemake continuous systems versatile in both the
clinical and commercial scales without the need for scale-up.
Continuous systems with automation and process control
result in high-quality (low-variability) products, whereas
batch processing is far less understood, resulting in often un-
predictable product quality [11]. Blend segregation has been
shown to be prominent in batch systems, while continuous
systems have demonstrated the ability to process segregating
mixtures without issue [19]. Moreover, a properly designed
continuous system handles small portions of material at any
given moment, increasing material monitoring scrutiny. This
is unfeasible for large-scale batch processes with a similar
throughput. Utilizing product and process understanding with
properly implemented online PAT, continuous manufacturing
readily fits the criteria needed to enable real-time release test-
ing (RTRt), leading to rapid and reliable batch release of high-
quality product. In spite of these vast advantages, continuous
manufacturing also has significant challenges, and if imple-
mented incorrectly, continuous processes will fail.
Two notable challenges are batch definition and raw mate-
rial traceability, both required by regulation. [20] This work
presents a method based on the residence time distribution
(RTD), which can be used to address both of these challenges.
The RTD is also used to examine the sensing frequency, with
the goal of defining a sensing speed that would ensure that any
unacceptable content uniformity variations would be detected
and handled. As a case study, a simplified quality risk
management process, including assessment and control, was
completed for a direct compression case study, which identi-
fied high-risk content uniformity issues and reduced them
through redesign that improved system robustness.
In the chemical processing field, the residence time distri-
bution (RTD) is used to describe how a material travels inside
the unit operations of a continuous process system. RTD is a
critical, yet underutilized tool in pharmaceutical process un-
derstanding, quality assurance, and equipment and sensing
design. Although traditionally applied to fluid systems [21],
there have been many publications showing this the same
probability-based time distribution also applies to granular
or powder systems. [22–30]
Continuous Manufacturing System
The model system used for the methods developed in this
work is the prototype continuous direct compaction (DC)
manufacturing system, which was developed and built by
the Engineering Research Center for Structured Organic Par-
ticulate Systems (ERC-SOPS, http://www.ercforsops.org/)
located at Rutgers University. A photo and model of the
continuous manufacturing platform are shown in Fig. 1a, b,
and a simplified model highlighting the unit operations is
shown in Fig. 1c. The continuous DC system was
constructed on a three-tiered scaffolding platform, which has
multiple loss-in-weight feeders on the highest level. The
feeders supply the multiple components of formulation
through to a Quadro Comil, which is located on the middle
level and serves a triple purpose. The Comil sieves breaking
large agglomerates, performs initial high shear mixing, and
ensures intimate contact of poorly flowing ingredients with
glidants, thus improving blend flow properties. Also, on the
middle level, the Comil’s exit passes milled material to a Glatt
continuous mixer, which consists of a horizontally rotating
shaft with triangular-shaped paddles that mix the blend as it
travels through the tubular body. An additional feeder supplies
lubricants (i.e., MgSt) directly to the blender, bypassing the
Comil. Following the mixer is a Kikusui tablet press, which
compresses the blended formulation into tablets at the ground
floor level.
Methods
Residence Time Distribution Experiments
The residence time distribution (RTD) can be easily obtained
for all unit operations in a continuous line with a tracer re-
sponse experiment performed for each unit operation separate-
ly and for the mechanically integrated line as well. In this
testing, a pulse or step change of tracer is added to the inlet
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of the continuous equipment being characterized, and the re-
sponse of the tracer concentration profile at the outlet is mea-
sured. The concentration measurements can be recorded using
online spectroscopy, or samples can be collected for off-line
measurement. In either case, it is important that the tracer
concentration be readily measureable by an analytical tech-
nique. Additionally, the presence of the tracer should not im-
pact the flow properties of the bulk material for which the
RTDmeasurements are being taken, because the RTD is high-
ly dependent on the flow behavior of the material within the
apparatus. Any significant changes to the flow behavior will
cause the measured RTD not to be representative of the
material.
Furthermore, the RTD can be sensitive to all process pa-
rameters, which means that the entire design space of a unit
operation needs to be investigated. This is particularly
important, because a continuous system with process control
will change process parameters to maintain a consistent
product.
For tracer pulse tests, the response will be a concentration
profile, C(t), that has the same shape as the residence time
distribution, E(t). The RTD can be calculated by normalizing
the concentration profile by the area underneath the profile:




It is important that the data set for the concentration profile
be completed and includes the entire tail. If the profile is not
complete or the tail is very long, the RTDwill be inaccurate. If
Fig. 1 ERC-SOPS prototype
direct compaction line located at
Rutgers University: a Photo of the
platform. bModel of the
platform. c Simplified model of
the system showing the connected
unit operations without the
scaffolding
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this occurs, it is possible to extrapolate the tail as an exponen-
tial decay, which will improve accuracy of an incomplete
dataset [31].
The tracer pulse technique also relies on the ability to add a
pulse that is as close to instantaneous as possible. If this is not
possible or the residence time is very short, this can also add
inaccuracies. However, when correctly applied, this method is
the most direct method for determining the RTD [31].
If the pulse technique is not reliable, an alternative is the
step change technique. For tracer step change tests, the re-
sponse will be a concentration profile with the same shape
as the cumulative distribution function (CDF), F(t). To calcu-
late the CDF, the concentration profile needs to be normalized
so that the initial value is 0 and the final value is 1:
F tð Þ ¼ C tð Þ−Cinitial
Cfinal
ð2Þ
where Cinitial and Cfinal are the initial and final tracer concen-
trations. Typically, the initial tracer concentration would be 0,
which simplifies this equation to:
F tð Þ ¼ C tð Þ
Ctracer
ð3Þ
The cumulative distribution function (step response) and
residence time distribution (pulse or point response) are relat-
ed by the following equations:
F tð Þ ¼
Z t
0
E tð Þ dt ð4Þ
E tð Þ ¼ dF tð Þ
dt
ð5Þ
A residence time distribution has several moments that can
be used to characterize its shape. For this study, only the first
two integer centered moments are used, respectively the mean
residence time and the variance (square of standard deviation).









t−τð Þ2E tð Þdt ð7Þ
The mean residence time can be used to quantify the center
of the residence time distribution, whereas the standard devi-
ation is used for determining its width. These moment values
are useful for describing the shape of a distribution without
relying on the entire distribution.
Residence Time Distribution Fitting
Continuous unit operations vary dramatically in both function
and geometry, and correspondingly, the residence time distri-
bution (RTD) of any unit operation is equally as varied. In
liquid flow and mixing applications, this has resulted in the
development of many RTD models, some of which may not
be appropriate for solid unit operations.
However, the examples shown in this work use the Bstirred
tanks in series^ model, which is an empirical model based on
equally sized continuously stirred tank reactors (CSTRs)
placed in series (see Fig. 2). The model for a CSTR assumes
a mixed vessel with perfect back-mixing. However, placing
CSTRs in series results in a model for realistic mixing.
Figure 3 shows a range of residence time distributions
modeled with tanks in series. The number of tanks in this
figure ranges from 1 up to infinity. A larger number of tanks
in series result in a narrower distribution. An infinite number
of CSTRs in series are equivalent to a plug flow tubular reac-
tor (PFR), which does not have any axial mixing and is rep-
resented by a pulse response.
Generalizing the model for tanks in series results in the
following equations for RTD [31]:
E tð Þ ¼ t
n−1
n−1ð Þ! τn
 n e −ntτð Þ ð8Þ
where τ is the mean residence time and n is the number of
CSTRs. The concentration profile for the pulse response test-
ing is similarly generalized by:
C tð Þ ¼ C0E tð Þ ¼ C0 t
n−1
n−1ð Þ! τn
 n e −ntτð Þ ð9Þ
where C0 depends on the amount of material added in the
pulse.
The RTD experimental data was fit to the tanks-in-series
model using a built-inMatlab function, Blsqcurvefit,^which is
a least squares curve fitting function based on the trust-region-
reflective algorithm described by Coleman et al. [32, 33]. The
concentration profile defining parameters (C0, τ, and n) are
determined by this least squares technique, which seeks these
values while minimizing the sum of square (SS) error between





C X ; tið Þ−Cið Þ
2
ð10Þ
where C(X,ti) is the estimated concentration, ti and Ci
represent the ith points from the experimentally collect-
ed time and concentration datasets, and X is the param-
eter set for the model:
X ¼ C0; τ ; n½  ð11Þ
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Convolution
A single residence time distribution can be used to trace the
passage of materials through a continuous flow system. Since
the RTD is the pulse or point response of the system, if the
system response is linear (i.e., if the tracer does not modify the
flow properties of the blend), any point in time will behave
and spread through the system just like a pulse of equal mag-
nitude. A measured input stream could be represented with a
string of discrete values representing the fluctuations in the
stream. Using the convolution integral for mixing:
Cout tð Þ ¼
Z t
0




0ð ÞE t−t0ð Þdt0 ð12Þ
represented in short hand by the convolution operator equa-
tion:
Cout tð Þ ¼ Cin tð Þ*E tð Þ ð13Þ
it is possible to predict the outlet of a unit operation as long as
the concentration of the inlet stream, Cin(t), and the RTD, E(t),
are both known. This can be extended to a series of unit op-
erations by calculating the overall RTD recursively, for exam-
ple, for two unit processes, as:
E tð Þ ¼ E1 tð Þ*E2 tð Þ ð14Þ
where E1(t) is the RTD from a first unit operation and E2(t) is
from a second operation.
This convolution technique is depicted in Figs. 4 and 5. In
Fig. 4a, the first RTD, E1(t), is discretized with approxima-
tions for the time interval of 2.4 s, where the discrete version
of the RTD is now represented by a sequence of bars.
Figure 4b shows the second RTD, E2(t), which is scaled for
each of the elements in the discrete approximation from
Fig. 4a and is plotted in Fig. 4c. For example, the first element
is 0 when t=0, which is why the peak of E2(t), 0.36 at t=5 s,
results in the scaled response of 0 at 5 s. The second element,
which is 0.0378 at t=2.4 s, results in a product of 0.033
(0.36*0.0378*2.4), which is the value shown for the peak of
the scaled response at t=7.4 (5 s+2.4 s). This was repeated for
all of the elements in the discrete approximation, while the
time was offset by 2.4 s for each subsequent approximation,
which was the time interval. These are then summed, and are
shown in Fig. 4d overlaid with the solution from the Matlab
Bconv^ function. The Bconv^ function uses a time interval
corresponding to the resolution of the RTD, which creates a
smooth solution in contrast to the example, which was limited
to the 2.4-s time interval. Figure 5 shows a plot of the two unit
operation RTDs, E1(t) and E2(t), with their convoluted solu-
tion or overall RTD, which is both broader and has a longer
mean residence time.
The Matlab function’s generalized definition is:





E2 tk−t j þΔT
 
ΔT ð15Þ
where ΔT is the time interval for the two RTDs and tk and tj are
the kth and jth points of the time array.
Traceability of Raw Materials in Continuous Processing
Systems
The overall process RTD can be determined using the mathe-
matical tool of convolution in combination with the residence
time distributions (RTDs) for each unit operation. Figure 6
shows a process flow diagram for a direct compaction
Fig. 2 Depiction of the tanks-in-
series model where n=3
Fig. 3 Residence time distributions for tanks-in-series model having a
mean residence time of 1 and a number of tanks ranging from 1 to infinity
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continuous manufacturing system. After the feeders at the top,
the first unit operation is a mill, which has a short and narrow
RTD. Next is the continuous blender, which has significant
back-mixing and therefore a broader residence time distribu-
tion. Finally is the tablet press, which has an even longer
residence time due to the feed hopper and the feed frame,
but only a small amount of back-mixing in the feed frame.
Combining these three unit operations through the convolu-
tion technique yields an overall system RTD, which is both
longer and wider than any of the individual unit operations.
This overall system RTD can be used to trace raw materials
across the entire system, all the way to the tablets.
RTD modeling of the system allows for tracking the evo-
lution of any process disturbance through the process so that
the affected downstream material can be easily identified as
well as backtracking to pinpoint the source of the disturbance
making it a useful predictive tool for risk management. How-
ever, RTDmodeling needs to be utilized with other tools to be
effective. For example, the ability to detect a disturbance is
contingent of having appropriate sensors in optimal locations.
Paired with an exceptional event management framework as
described by Hamdan et al. [34], RTD modeling can provide
the mapping needed for corrective action needed for excep-
tional events in the form of dynamic process changes or re-
moval of out of specification material. The result is reduced
variability and an improvement in product quality.
For simplicity of this depiction in Fig. 6, the RTD of the
feeders and feeder refill system is not shown, but to trace raw
material back to a drum will require mapping those unit oper-
ations as well. The method for this or other continuous sys-
tems is the same. The RTD for each feeder will be unique to
the equipment and powder used under the actual operation
conditions used. Because of this, each component will have
a separate overall residence time distribution. This would be
the case anytime multiple streams are combined. For example,
consider a process to create a bi-layer tablet. The process
Fig. 4 Visual representation of the convolution technique for two
residence time distributions (RTDs), E1 and E2. a Discrete approximation
of E1. b E2. c E1’s discrete approximation-scaled responses of E2
and their sum. d Sum of impulse responses for a time interval of 2.4 s
and result from convolution function
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would involve separate blending of the blend used to make
each side of the tablet, usually in unequal proportion and hav-
ing a different composition (i.e., a different active pharmaceu-
tical ingredient (API)) causing the ingredients in the two sides
to have different RTDs. However, RTDs vary monotonically
with respect to material properties and processing conditions;
thus, the development for predictive correlations for RTDs is
entirely feasible [35].
BBatch^ Definition
One of the early barriers to developing and implementing
continuous processing was, and to some extent remains, un-
certainty regarding regulatory compliance. One of the main
concerns is the ability to trace materials by batch and lot, a
regulatory requirement. According to 21 CFR 210 [36], the
definitions of batch and lot are:
Batch BA specific quantity of a drug or other material that is
intended to have uniform character and quality,
within specified limits, and is produced according to
a singlemanufacturing order during the same cycle of
manufacture.^
Lot Ba batch, or specific identified portion of a batch,
having uniform character and quality within specified
limits’ or, in the case of a drug product produced by
continuous process, it is a specific identified amount
produced in a unit of time or quantity in a manner that
assures its having uniform character and quality
within specified limits.^
Fig. 6 Residence time distribution of the individual unit operations and overall system
Fig. 5 Representation of the convolution of two residence time
distributions (RTDs), E1*E2, plotted with the two component RTDs,
E1 and E2
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The regulatory definition of batch has no stipulation or
requirement as to the method of manufacture, and in fact,
the definition of lot specifically includes continuous process-
ing. It is still necessary to define batch and lot to comply with
various aspects of current good manufacturing practice [20,
37]. Compliance requires:
& Batch production and control records
& Laboratory conformance testing and release
& Investigation of failures or discrepancies
& Recall procedures
While both batch and lot are defined, precise specification
of each is left to the manufacturer’s discretion and design. For
a continuous manufacturing process, specification may be
based on production time period, amount of material, variation
in production, or maintenance cycles. A variation in produc-
tion, such as a change in feedstock lot, may be the most ap-
propriate method as a batch is Bintended to have uniform
character and quality^ [36].
In a batch process, the Bbatches^ are physically separated
into enclosed vessels, making batch identification straightfor-
ward (see Fig. 7a). In continuous manufacturing, a physically
separated Bbatch^ does not exist; instead, a continuous non-
stop stream of product is generated. The lack of a physical
barrier between batches in a continuous process causes the
boundaries between batches to become confounded because
of back-mixing across the system. A naive and unrealistic
view of batch specification for a continuous processing might
assume that there is no back-mixing. However, this is only
true for an ideal plug flow system (see Fig. 7b), in which an
arbitrary boundary would suffice and then the identification
would be similar to that of batch processing. Such a plug flow
system, however, would have no back-mixing capabilities and
therefore would be unable to eliminate any variability entering
the system due to either material properties or processing con-
ditions. Thus, substantial back-mixing would be an intrinsic
characteristic of any robust and effective continuous
manufacturing process, and batch definition must address its
presence.
Therefore, in a realistic continuous system (see Fig. 7c),
which would have some amount of back-mixing, materials
would comingle between subsequent batches. Although there
is no specific regulatory conformance problem with using an
arbitrary division, it must be determined how many batches
are affected by any potential manufacturing inconsistency.
Additional procedures would need to be developed to address
these inconsistencies. See Fig. 7c for an example. In this case,
if there were a need to recall BBatch 3,^ then, it must be
assumed that the recall might also apply to BBatch 2^ and
BBatch 4.^As the batches may be quite large, this would result
in a large amount of recalled or rejected material. To solve this
problem, smaller batches could be used, resulting in less ma-
terial loss, but increased release-related testing (thus empha-
sizing the importance of RTRt). With any batch size, experi-
mental qualification of the equipment must be determined to
properly identify the batches that should be considered
adulterated.
An alternative to drawing an arbitrary line between batches
in a continuous system would be to separate the interface
region between batches and define the batch as the material
between the interfaces. See Fig. 8. In the case where batches
are specified by a component lot change, this method would
ensure that each batch contains only a single feedstock lot.
Removing the interface is analogous to the removal of the first
and last parts of a batch made by batch processing, which is
often performed to maintain uniform quality. However, the
need to do this in batch processing is due to actual quality
problems, such as blend segregation. In continuous
manufacturing, such quality problems are minimized; thus,
the possible need to discard the interface is entirely a regula-
tory compliance issue.
In continuous processing, the size of the interface between
batches can be minimized using experimentally measured
Fig. 7 Visual comparison of
batch definition for a Btraditional^
batch processing, b continuous
Bplug flow^ processing, and c
realistic (non-plug flow)
continuous processing. The
dotted lines represent arbitrary
divisions between batches
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RTDs. Since the RTD represents the pulse response of the
system, it can be applied to represent the point response from
a feedstock lot change, which behaves exactly like a tracer
step change. For example, given the RTD measured from a
continuous blender shown in Fig. 9a, the cumulative distribu-
tion function (CDF), F(t), shown in Fig. 9b can be derived.
The CDF represents the fraction of new feedstock that will
exit in the outlet stream as a function of time. For instance, the
value is 0 at t=0, meaning none of the new feedstock will be
exiting. When the value of the CDF becomes 1, the old feed-
stock has completely exited and only the new feedstock would
be exiting. The old feedstock would follow the inverse wash-
out profile, represented by:
W tð Þ ¼ 1−F tð Þ ð16Þ
As an example, batch boundaries were defined using 0.5
and 99.5%, which are shown by the vertical lines in Fig. 9a, b.
At a time of 30 s, the new feedstock would start to appear at
the outlet of the system. At 160 s, the last of the old feedstock
has left the system and the outlet only contains the new feed-
stock. Therefore, the material exiting from 30 to 160 s could
be discarded as the transition interface (or released as a sepa-
rate Bbatch,^ to be recalled if necessary). The material before
and after this time interval becomes two different and separate
batches. The result is a short 130-s interface. At a total pro-
cessing throughput for a formulation of 30 kg/h, the discarded
interface would amount to about 1 kg of material. This is
modest compared to the often used procedure of discarding
the first and last portions of large batch-processed batches.
Results
Identifying Sources of Disturbances
A quality risk management process should include the assess-
ment, control, communication, decisions, and review of risks
to the quality of the drug product across the product life cycle.
[38] In the work presented here, the focus is specifically on the
first two parts, assessment and control, as they relate to content
uniformity. A risk assessment includes identifying hazards,
estimating the risk, and evaluation. Although there are an in-
finite number of hazards that can occur in any process, any
unmonitored risk is based on both the probability and severity
of the hazards. However, adequate detection and process con-
trols can be utilized to reduce or eliminate risks.
In a continuous direct compaction line, the highest proba-
bility for content uniformity risk is at the feeders and blender.
Assuming the blend is uniform at the exit of the blender, there
is a very low risk of content uniformity issues arising. A prop-
erly designed continuous blender should have no dead zones
and should have enough radial mixing to blend multiple com-
ponents into a uniform mixture. Typically, the real issue is not
the blender, but instead the composition of the inlet stream. If
the ingredients in the inlet streams are not entering the blender
Fig. 8 Depiction of batch definition for continuous processing, which removes the interface regions (in yellow boxes) between batches. The remaining
material between these regions then become the batches (in green boxes)
Fig. 9 Define the boundaries of a batch for a continuous process by using
a residence time distribution (RTD) and b cumulative distribution
function (CDF). The boundaries shown here are 0.5 and 99.5 %, which
may not be the ideal values, but were chosen to demonstrate this exercise
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at the correct ratios, no amount of blending will correct the
composition of the blend. The feeders and the downspout
from the feeders are the most likely cause of content unifor-
mity risks.
The recommended feeders for pharmaceutical continuous
processing are loss-in-weight feeders, which use internal
gravimetric control based on load cell measurements. Gravi-
metric control greatly reduces the risk of feeder error.
However, a few hazards that may arise have been identified
as the following:
& Poor load cell calibration can cause the feeder to dispense
at the wrong rate with the feeder’s controller unable to
detect an issue. This is an operator error that will require
system shutdown to correct. Detection depends on down-
stream PAT or monitoring the feeder’s drive speed. A cal-
ibration problemmay be indicated by significant deviation
from the historic behavior of the feeder’s screw speed
while the reported load cell measurements remain within
range.
& Some feed rate fluctuation (see Fig. 10a) is unavoidable.
Fluctuation can be minimized with proper design, but still
poses a potential risk.
& Disturbances can lead to deviations (i.e., hopper refill).
See Fig. 10b. The most common cause of significant de-
viations in the feed rate of the feed stream is caused during
hopper refill. When refilling, the feeders temporarily op-
erate in volumetric mode and therefore do not correct for
the density changes associated with hopper refill. This can
be minimized with refill scheduling optimization, but still
needs to be considered a potential risk [39].
& Downspout accumulation (see Fig. 10c) can cause a sud-
den rise in concentration of a component if accumulated
material suddenly breaks off and falls. This typically indi-
cates a design problem and requires redesign. However,
small accumulation may still occur.
& Feeder bearding (see Fig. 10d) can also pose a risk when
the material suddenly discharges and falls.
This above list of common feeding hazards is not exhaus-
tive. Depending on the formulation and process, there may be
other unlisted hazards, or the ones listed here may not be
relevant. The cases displayed in Fig. 10 are all extreme cases
and will not necessarily occur to the same degree with every
powder. These can be summarized into two different cases
that require analysis: fluctuations and pulse disturbances.
Feeder Fluctuations and Filterability of the Mixer
Due to the intrinsic physics of powder flow, there will be some
degree of variability in the feed stream. This variability can be
minimized through feeder and tooling selection [40–42], but
in any case, these fluctuations need to be quantified, and the
system needs to be designed to handle these unavoidable var-
iations. Typically, feeders would feed individual components
into a continuous blender, blending them into a homogenous
mixture through radial mixing. If the blender were a perfect
plug flowmixer, then, the variations from the feeders will pass
through the blender causing variations in content uniformity.
Axial mixing within the blender enables a secondary function
of smoothing or filtering out feeder variability. The degree to
Fig. 10 Sources of content
uniformity variability: a feeder
fluctuations, b deviations caused
by refill, c downspout
accumulation, d feeder bearding
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which this occurs depends on the residence time distribution
of the blender and the magnitude and frequency of the fluctu-
ations from the feeder.
The relations between the feeder and the blender can be
evaluated using the Fourier series analysis demonstrated by
Gao et al. [43] This paper defines the filterability, which quan-
tifies a blender’s variance reduction ratio as a function of the
frequencies of fluctuations. The filterability function can be
derived from any residence time distribution. Similarly, the
feed stream from a feeder can also be transformed into the
frequency domain [40, 41].
The effect of residence time distribution on an incoming
feed stream is shown in Figs. 11 and Fig. 12. Figure 11a shows
a very narrow RTD, and Fig. 12a shows a broad distribution.
Using the same feed stream, a bi-modal sine wave with fre-
quencies of 0.05 and 0.1 z results in a very different behavior
as shown in Figs. 11b and 12b. For the narrower distribution,
the bi-modal sine wave is only shifted in the time scale, but the
Fig. 11 Simulated results for a
bi-modal sine wave feed stream
being fed to a blender with a
narrow residence time
distribution (in comparison to
Fig. 12). a Residence time
distribution. b Concentration
profiles for the inlet and outlet of
the blender. c Calculated filtering
ability of the blender as a function
of frequency. d Frequency
domain of inlet and outlet streams
Fig. 12 Simulated results for a
bi-modal sine wave feed stream
being fed to a blender with a
broad residence time distribution
(in comparison to Fig. 11). a
Residence time distribution. b
Concentration profiles for the
inlet and outlet of the blender. c
Calculated filtering ability of the
blender as a function of
frequency. d Frequency domain
of inlet and outlet streams
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shape is nearly identical before and after the blender. For the
broad distribution, which has significantly more back-mixing,
the higher frequency is filtered out, and the amplitude of the
lower frequency is reduced. These results are more clearly
reflected in the frequency domain plots of Figs 11d and 12d.
For the filtering ability plots in Figs. 11c and 12c, a value of
1 indicates that fluctuations will pass through, and a value of 0
indicates that the fluctuation has been spread and therefore
reduced in magnitude. Figure 11c shows the filtering ability
for the narrow distribution, which will not filter out most fluc-
tuations with frequencies longer than 0.15 Hz. In contrast,
Fig. 12c shows the filtering ability for the broad distribution,
which filters most fluctuations above 0.05 Hz.
The effect of changing the parameters of the tanks-in-series
model is shown in Figs. 13 and 14. Figure 13a shows the
residence time distributions as the number of tanks was in-
creased from 1, which resembles a CSTR, up to infinity,
which resembles that of a PFR. As the number of tanks was
increased, the variance of the distribution decreases, which is
indicated by a narrower distribution. Figure 13b shows that as
the number of tanks increased, the ability to filter fluctuations
decreased, which is indicated by the filterability increasing
towards a value of 1.
Figure 14a shows the effect of increasing mean residence
time on the shape of the residence time distribution. The mean
residence timewas increased from 1 to 25 s using the tanks-in-
series model. Due to the arrangement of parameters within the
equation of the model, an increase in mean residence time also
increases the variance, which is shown by the broadening of
the distribution. This resulted in a significant amount of back-
mixing, which improved the ability to filter fluctuations as
shown in Fig. 14b. Since the tanks-in-series model is a
mono-modal distribution, filtering ability tends to decrease
Fig. 13 Effect of changing number of tanks in the tanks-in-series model:
a residence time distribution and b ability to filter fluctuations of different
frequencies
Fig. 14 Effect of changing the mean residence time in the tanks-in-series
model: a residence time distribution and b ability to filter fluctuations of
different frequencies
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down to 0 with increasing frequency. This indicates that lower
frequencies are more likely to pass through, whereas higher
frequencies will be smoothed and filtered out entirely.
Traceability of Pulse Disturbances
Simulated Pulse Disturbances
With the potential hazards identified, the next step of a quality
risk assessment is risk analysis and evaluation. Hazards
affecting content uniformity have a high potential to produce
harm and need to be addressed. For most of the hazards iden-
tified above, the result is a sudden pulse-like addition of a
component, which may cause a significant deviation from
product content specification. Using the residence time distri-
butions for each unit operation and the system as a whole, the
significance of any pulse addition can be quantified via
simulation.
Consider a pulse input into the mill, such as from feeder
bearding or downspout accumulation breaking off and falling.
Fig. 15 Simulation results
showing the active
pharmaceutical ingredient (API)
concentration profile for the
various unit ops and their
response to a pulse of API added
to the entrance to the mill. The
blender has a mean residence time
of 41.6 s and a standard deviation
of 12 s. The sizes of the pulse are
a 0.25 and b 1 g
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Figure 15a shows the response of a 0.25 g pulse into a direct
compaction system with an overall throughput of 30 kg/h and
a nominal active pharmaceutical ingredient (API) concentra-
tion of 6%. The API pulse in the feed stream occurred at 300 s
with the response from the mill immediately following. The
spike in API concentration after passing through the blender
occurred between 325 and 375 s, which added a significant
amount of spreading due to back-mixing. Finally, the tablets
exited between 800 and 900 s. This resulted in tablets within
specification, <7.5 % (125 % of 6 %), meaning that no action
was needed. However, if the pulse was increased to 1 g, as
shown in Fig. 15b, there would be tablets out of specification
(OOS). In this case, detection of the disturbance should trigger
an exceptional event and corrective action should be taken,
such as the removal of the OOS material from the product
stream. Without predictive modeling, this would present a
significant challenge. If material testing indicates a high prob-
ability of one of the identified hazards rather than a rare ex-
ceptional event, then, the system should be designed to handle
that hazard, which is quality by design (QbD). Figure 16
shows the results for a system where the blade pattern in the
continuous blender was changed, which caused it to have a
broader residence time distribution. This resulted in a more
robust system that could handle a 1 g pulse of the API without
generating OOS product.
Sampling Frequency/Adequate PAT
Online process analytical technology is crucial for control of
any continuous manufacturing process. However, its imple-
mentation is not as simple as adding sensors to measure prop-
erties of the blend at various stages in the system.
Measurement needs to be meaningful, which requires a mea-
surement that is representative, accurate, and timely. In batch
manufacturing, the challenge is typically obtaining a measure-
ment that is representative of the batch, because sensors or
sampling is very localized. In continuous manufacturing,
timely measurements are the larger challenge.
It is important to highlight a critical difference between a
batch process and a continuous process. A batch process
varies with time, whereas a continuous process varies primar-
ily with respect to the spatial dimension. This means that the
measurement at a fixed location in a batch process will be
different at the beginning as opposed to the end. In a contin-
uous process, this is not the case. If a sensor was fixed at the
entrance to a continuous blender, the sensor would see the
individual unmixed components throughout the entire pro-
cessing time. If the sensor was fixed at the exit of the blender,
the sensor would see a fully mixed blend after a short steady-
state start-up time and until the line is shutdown. A sensor in a
batch process only measures the final blend at the end of
processing, whereas a continuous process conducts many
measurements of small sections of the final blend throughout
processing. Therefore, the measurements from the continuous
process are more representative of the entire product stream
(and therefore of entire batches).
In a continuous system, the most meaningful measurement
is to characterize the intensity and frequency of fluctuations in
the process stream. This means the sensors must be fast
enough to detect any of these disturbances, ensuring nothing
important passes the sensor undetected. This would be equiv-
alent to a high concentration pocket or a segregated section
not being detected in a batch process, due to the section not
being within a sampling region. To ensure that this does not
Fig. 16 Simulation results
showing the active
pharmaceutical ingredient (API)
concentration profile for the
various unit ops and their
response to a 1 g pulse of API
added to the entrance to the mill.
The blender has a mean residence
time of 71.7 s and a standard
deviation of 24.9 s
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occur in continuous processing requires investigating how a
fluctuation would spread in the process. The most difficult
fluctuations to detect in a feed stream are narrow pulses, but
as they progress along the system, pulses are spread based on
the residence time distribution (RTD). Thus, the RTD contains
the information needed to design the sensing system in order
to ensure that pulse fluctuations do not travel through the
system undetected.
Figure 17 shows an example residence time distribution
from the continuous blender. In this plot, the mean (68.8 s)
is represented with a single vertical red line, and the standard
deviation (22.4 s) is represented with two vertical green lines
spaced on either side of the mean by the value of the standard
deviation. It is logical to assume detection of the downstream
response is easier than detecting the pulse disturbance itself. If
the system were Bplug flow,^ the perturbation would be large-
ly unchanged as it travels along the system, meaning that a
pulse into the system would result in a pulse response. This
would be difficult to detect without a very rapid measurement.
Fortunately, this is not the case, and the sampling frequency
only needs to be fast enough to catch a disturbance equivalent
in shape to the RTD. A reasonable approach is to use a sam-
pling or measurement regime that results in three to five mea-
surements across the time interval represented by double the
width of the RTD, which is quantified by its standard devia-
tion. The following equations can then be used to define the
maximum time between sampling and the minimum sampling
frequency:







where nsamples represents the number of samples and σ is
the standard deviation of the RTD. For the RTD represented in
Fig. 17, this would result in a sampling time of 8.96 to 14.93 s
or a sampling frequency of 0.07 to 0.11 Hz. Utilizing high-
frequency PAT sensors as defined by Eq. (18) would ensure
adequate sensing to determine the approximated shape of the
RTD. Aided by a simple peak detection algorithm, most sig-
nificant spikes can be easily detected.
However, using 125 % concentration as an upper limit for
detection with a binary Bpass/fail^ outcome may result in
smaller anomalies passing the PAT system undetected,
resulting in small amounts of super-potent product, unless
the sampling frequency is extremely high. Figure 18 shows
the pulse response to various size pulses that result in differing
amounts of super-potent product. The percentages for out of
specification (OOS) product were calculated based on an as-
sumed Bbatch^ size based on a single disturbance event occur-
ring once per 15 min (900 s) of continuous processing. Large
deviations such as the one that results in 5 % OOS product, as
shown in Fig. 18, will be detected easily as there will be
several measurements indicating OOS material. However,
the smaller deviations, 1 and 2 % OOS, do not exceed
125 % API concentration by much nor for very long, making
online detection a challenge.
Figure 19 shows the percent chance of detection of a single
pulse disturbance of various magnitudes, resulting in 1, 2, and
5 % OOS product, as a function of increasing sampling rate.
The percent chance of detection is represented by the follow-
ing equation:
Dcontinuous ¼ tbatch f samplingP ¼ nsamplesP ð19Þ
where P represents the percent of material that is over the
upper limit, fsampling is the sampling frequency, and tbatch is the
total time per batch (15 min=900 s).With increasing sampling
Fig. 17 Residence time distribution with vertical lines representing the
mean (68.8 s in red) and standard deviation (22.4 s in green). The
sampling interval represented by the diamonds is 8.96 s, which was
selected based on using five points across double the standard deviation
Fig. 18 aAPI concentration pulse response resulting in various amounts
of OOS material with a pass/fail value of 125 % API concentration. b
Zoomed version for better resolution of the peak
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frequency, the probability of detecting a single exceptional
event increases and eventually reaches 100 % for all three
cases. Since the larger deviations are easier to detect, the de-
tection percent is highest for 5 % OOS at any sampling fre-
quency, which is followed by 2 %OOS, and finally 1 %OOS.
The chance of detection reaches 100 % at the following sam-
pling frequencies (and sampling time intervals) for the various
deviations: 0.022 Hz (45 s) for 5 % OOS, 0.056 Hz (18 s) for
2 % OOS, and 0.111 Hz (9 s) for 1 % OOS. This means that at
any of these sampling rates, there is 100 % coverage for de-
viations of that respective size. However, as the percent of
OOS material decreases closer to 0 % the ability to detect
these very small deviations requires infinitely faster sensing.
To increase the ability of slower or less accurate PAT sen-
sors to detect OOS material, the upper limit for the binary
pass/fail criteria should be lowered. To detect a deviation at
even the smallest deviation above 125 % requires sensing the
limit where a single point reaches 125%. Figure 20 shows this
limiting concentration profile that peaks at 125 % API con-
centration and shares the shape of the RTD displayed in
Fig. 17. Lowering the upper limit to 121.75 % results in ma-
terial that exceeds the limit for 22.4 s, which is also the stan-
dard deviation of the RTD. Assuming a sampling frequency as
defined by Eq. (18) would ensure that a fewmeasurements are
made during this interval allowing for adequate detection.
Figure 21a shows a depiction of the material that would fail
if the upper limit were reduced to 121.75 %, and Fig. 21b
shows the corresponding chance of detection plotted as a func-
tion of increasing sampling frequency. The chance of detec-
tion reaches 100% at the following sampling frequencies (and
sampling time intervals) for the various deviations: 0.02 Hz
(50 s) for 5 % OOS, 0.036 Hz (28 s) for 2 % OOS, and
0.042 Hz (24 s) for 1 % OOS. For comparison, the similar
plots are also shown as dotted lines for the case using 125% as
the upper limit. For the smaller deviations, 1 and 2 % OOS,
the improved detection ability is dramatic, whereas the larger
deviation, 5 %, has less improvement.
The advantage of the continuous measurements of PAT
versus sampling of a batch after processing is shown in
Fig. 22. The sampling frequency for the continuous PAT
Figure 19 Probability of detection as a function of sampling frequency
for pulses resulting in various amounts of OOS material: 1, 2, and 5 %
Fig. 20 Concentration profile for a pulse response resulting in a peak of
125 % concentration. The red horizontal dotted line indicates a 121.75 %
limit and the two vertical blue dotted lines indicate the width of the
standard deviation (22.4 s) of the corresponding RTD, which is shown
in Fig. 17
Fig. 21 aAPI concentration pulse response resulting in various amounts
of OOS material with a pass/fail value of 121.75 % API concentration. b
Probability of detection as a function of sampling frequency for pulses
resulting in various amounts of OOS material: 1, 2, and 5 % for both
121.75 % limit and 125 % limit. OOS material is determined by 125 %
limit in both cases
Fig. 22 Probability of detection as a function of sampling frequency for
pulses resulting in various amounts of OOS material: 1, 2, and 5 % for
both a continuous process with online PAT (solid lines) and a batch
process (dotted lines) with off-line random sampling. OOS material is
specified by an upper limit of 125 % concentration, and the limit used
for detection is 121.75 % concentration
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measurements were translated into number of samples based
on an assumed 15 min of processing for a batch allowing for
direct comparison to a batch with a similar amount of OOS
material. Differing from the continuous case which utilizes
PAT, the batch curve assumes the sampling is completely ran-
dom:
Dbatch ¼ 1− 1−Pð Þnsamples ð20Þ
PAT sensors in a continuous system have a set sampling
frequency, which ensures that each measurement is observing
a different section of material. Therefore, the sampling cover-
age and ability to detect all deviations will rapidly approach
100 %, at which point no deviation will pass the sensors un-
detected. To reach this same amount of coverage, a completely
random or batch process will require orders of magnitude
more samples. An initial comparison of continuous versus
batch processing made from this plot is that there will be more
correctly failed batches for a continuous process. However,
this is not entirely the case, as these PATsensor measurements
allow downstream batch correction, such as a rejection chute,
ensuring batches that would have failed do not contain any
OOS material and therefore are of higher quality than batch
processing with random sampling could ever achieve.
Conclusions
Methods were presented to address challenges of batch defi-
nition, raw material traceability, and adequate PAT sensor fre-
quency as it pertains to continuous manufacturing with refer-
ence to regulatory requirements. At the present time, available
ICH guidances offer little explanation on implementation for
continuous systems. Although batch definition is left open for
the manufacturer to specify, other requirements, such as re-
cording specific identification for each component within the
batch records, make production changes, such as a feedstock
lot change, a favorable factor for specification. To minimize
crossover between batches, it was suggested to measure resi-
dence time distribution to quantify and define reasonable
boundaries to remove the interface between batches, which
may contain multiple batches of components.
To access and control risks associated with content unifor-
mity, higher probability hazards were identified, categorized,
and discussed. Solutions to these potential risks were present-
ed where raw material traceability was a prevalent focus and a
significant part of the solution. Residence time distribution
(RTD) play an important role in raw material traceability as
it characterizes the spreading of the materials through the sys-
tem. Thus, a disturbance could be predictively tracked through
the entire continuous system, allowing for downstream con-
trol or even removal of the affected material. Coupled with a
diagnostic system, corrective action at the onset of a distur-
bance is possible (i.e., fault mitigation).
An important requirement of any PAT instrumentation is
the reliability of the measurements, which includes a sensing
frequency high enough to detect all significant disturbances.
Since pulse disturbances would require an extremely fast sen-
sor for detection, it was suggested that a downstream sensor
could be used. This would not require such high-frequency
sensing, but instead would only need sensing fast enough to
detect the downstream response, which would have the shape
of the RTD. This resolves the potential issue of OOS material
passing through to the product undetected and also sets up
some of the conditions needed for real-time release testing
(RTRt). RTRt also requires verification that the measurements
from PAT instrumentation reflect the testing results that would
be collected in traditional batch release testing.
Although the methods described focus on direct compaction,
they apply to any continuous processing system. To apply these
methods to other continuous formulating techniques requires on-
ly minor changes. Together, the methods presented in this work
bring continuous processing in the pharmaceutical industry to the
point of understanding for actual commercial installations.
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